Erudio Healtherudio.com
Sponsor
University of Sydney trials: what clinicians said in public
No HCP commentary report on a trial sponsored by University of Sydney yet. Erudio has found public clinician commentary on 4 clinical trials sponsored by University of Sydney: DASL-HiCaP, ENZAMET, ENZARAD and P3BEP. Each trial's page lists the podcasts, videos and posts found so far and the price of a report.
Listed by lead sponsor as registered on ClinicalTrials.gov (University of Sydney). A trial led by a partner or a research group is on that sponsor's page. Only trials with public clinician commentary found are listed, not every trial the sponsor runs.
| Trial | Indication | Phase | Statements | Sources | Size | Checked | Preview |
|---|---|---|---|---|---|---|---|
| No report yetTrials with public commentary we haven't built a report for. Size is an estimate of the verified statements the commentary we've indexed so far will yield; final coverage is set when we build the report, within 24 hours of your confirmed order. You never pay more than quoted: a report delivered at a smaller size costs that size's price. Some can also be requested as a free preview. | |||||||
| ENZAMET NCT02446405 · University of Sydney DeepView → | metastatic hormone-sensitive prostate cancer | Phase 3 | Deep | View | |||
| DASL-HiCaP NCT04136353 · University of Sydney DeepView → | very high-risk clinically localised prostate cancer | Phase 3 | Deep | View | |||
| ENZARAD NCT02446444 · University of Sydney DeepView → | high-risk clinically localised prostate cancer | Phase 3 | Deep | View | |||
| P3BEP NCT02582697 · University of Sydney FocusedView → | intermediate and poor-risk metastatic germ cell tumors | Phase 3 | Focused | View | |||